MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.

Pomalidomide-PEG1-CO2H 是一种合成的 E3 连接酶配体-连接子缀合物，含有基于 Pomalidomide 的 cereblon 配体和 2 单元 PEG 连接子。

Cinobufotenine 是一种副交感神经节兴奋剂，可被六甲铵竞争性拮抗。